Digital health firm Butterfly Network, Inc. (NYSE: BFLY) takes a significant leap in ultrasound technology with the commercial launch of its third-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3. The device, receiving FDA clearance last month, signifies a breakthrough in semiconductor-based ultrasound technology.
Powered by Butterfly’s most advanced semiconductor chip, the Butterfly iQ3 boasts double the data transfer rate of its predecessor, resulting in unparalleled image quality and faster micro-beamforming. The device introduces two groundbreaking 3D imaging capabilities: iQ Slice and iQ Fan, alongside best-in-class, high-resolution image quality.
Joseph DeVivo, Butterfly Network’s President, CEO, and Board Chairman, sees the iQ3 as a pivotal moment, validating the company’s vision that semiconductor-based digital ultrasound is the future. The device sets a new standard, matching the image quality of traditional handheld devices, attracting seasoned POCUS experts and supporting new learners through advanced imaging tools.
A blind survey by third-party vendor Intellisurvey, involving 475 clinicians, ranked Butterfly iQ3’s overall image quality higher than that of GE Vscan Air CL across various specialties.
The iQ3 introduces novel tools: iQ Slice, the world’s first automated sequential ultrasound capture mode on a handheld device, and iQ Fan, a dedicated lung tool for real-time, virtual fanning. These advancements simplify image capturing, enhancing precision and speed.
The Butterfly iQ3 hardware platform, developed in collaboration with Taiwan Semiconductor Manufacturing Company Limited (TSMC), features the innovative P4.3 chip. The chip, the foundation of the iQ3, improves device performance across the board, resulting in advanced imaging capabilities.
Butterfly iQ3’s new user-centric ergonomic design is smaller, lighter, and better distributed, with a 17% smaller probe face, 7% shorter probe, and a 2.5x faster charge time. These enhancements improve intercostal access, reduce physical strain on scanners, and ensure better control during scans.
John Martin, MD, Butterfly Network’s Chief Medical Officer, emphasizes that Butterfly iQ3 is designed to meet the needs of end users, providing immediate boot-up to clear imaging, long run time, fit-in-hand comfort, customizable controls, and rapid charging.
As of February 13, 2024, Butterfly iQ3 is available to healthcare providers in the United States for $3,899 plus membership.
The Butterfly iQ3 launch follows the recent release of ScanLab, an AI-powered educational application for ultrasound scanning practice, compatible with Butterfly iQ3 and prior generations.
